A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer.
Kim YJ, Keam B, Ock CY, Song S, Kim M, Kim SH, Kim KH, Kim JS, Kim TM, Kim DW, Lee JS, Heo DS.
Kim YJ, et al. Among authors: kim dw, kim sh, kim m, kim js, kim tm, kim kh.
Lung Cancer. 2019 Oct;136:122-128. doi: 10.1016/j.lungcan.2019.08.031. Epub 2019 Aug 29.
Lung Cancer. 2019.
PMID: 31494530
Clinical Trial.